Affiliation:
1. Department of Thoracic Surgery, the Second Affiliated Hospital of Medical School, Xi’an Jiaotong University, Xi’an, Shaanxi, China
Abstract
The ribosomal protein (RP)‐p53 pathway has been shown to play a key role in apoptosis and senescence of cancer cells. miR-1908 is a newly found miRNA that was reported to have prognostic potential in melanoma. However, its role and mechanism in the progression of non-small cell
lung cancer (NSCLC) are largely unknown. In this study, we found that expression of miR-1908 was significantly downregulated in human NSCLC cell lines, including SK-MES-1, A549, and NCI-H460. Then the role of miR-1908 in NSCLC cell proliferation was explored. The miR-1908 mimic was transfected
into NSCLC cell lines, and their proliferation was detected. MTT and Cell Titer-Blue H analyses showed that the cell proliferation was notably reduced by the miR-1908 mimic transfection. Moreover, we found the RP‐p53 pathway was activated by miR-1908 mimic. Moreover, the miR-1908 inhibitor
transfection had a completely opposite effect on the NSCLC cell proliferation than that of miR-1908 mimic. To explore the underlying mechanism of that, TargetScan bioinformatics server and 3′-UTR luciferase reporter assay were applied to identify the targets of miR-1908. Our results
showed that AKT1 substrate 1 (AKT1S1), a newly proven suppressor of the RP‐p53 pathway, was a target of miR-1908, suggesting a probable mechanism for miR-191 suppressing NSCLC cell proliferation. Our findings provide a novel molecular target for the regulation of NSCLC cell proliferation.
Subject
Cancer Research,Oncology,General Medicine
Reference30 articles.
1. Global cancer statistics;CA-Cancer J. Clin.,2011
2. Report of cancer incidence and mortality in China, 2010;Ann. Transl. Med.,2014
3. Non-small-cell lung cancer;Lancet,2011
4. Non-small cell lung cancer;J. Natl. Compr. Cancer Netw.,2012
5. PKB/Akt a key mediator of cell proliferation, survival and insulin responses?;J. Cell. Sci.,2001
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献